NFEPP

NFEPP
Clinical data
Other names	3-Fluorofentanyl
Drug class	Opioid
Legal status
Legal status	US: Schedule I;
Identifiers
	IUPAC name N-(3-Fluoro-1-phenethylpiperidin-4-yl)-N-phenylpropionamide;
CAS Number	1422952-84-8;
PubChem CID	71605072;
ChemSpider	58826238;
UNII	NXR38LA4PA;
CompTox Dashboard (EPA)	DTXSID101040109 ;
Chemical and physical data
Formula	C22H27FN2O
Molar mass	354.469 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCC(=O)N(c1ccccc1)[C@H]2CCN(C[C@H]2F)CCc3ccccc3;
	InChI InChI=1S/C22H27FN2O/c1-2-22(26)25(19-11-7-4-8-12-19)21-14-16-24(17-20(21)23)15-13-18-9-5-3-6-10-18/h3-12,20-21H,2,13-17H2,1H3/t20-,21+/m1/s1; Key:DMCQJJAWMFBPOX-RTWAWAEBSA-N;

NFEPP (N-(3-fluoro-1-phenethylpiperidin-4-yl)-N-phenylpropionamide) is an analgesic opioid chemical, similar in structure to fentanyl, designed in 2016 by Spahn et al. from Free University of Berlin to avoid the standard negative side effects of opiates, including opioid overdose, by only targeting inflamed tissue.